SA0007879188
SA0007879188
Saudi Pharmaceutical Industries
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 3.64B EUR | 3.37B EUR | 3.64B EUR | 3.11B EUR |
Enterprise Value | 4.87B EUR | 4.61B EUR | 4.76B EUR | 4.34B EUR |
Valuation Multiples | ||||
Trailing P/E | 17.02x | 15.73x | 20.35x | 27.4x |
Forward P/E | 23.8x | -- | -- | -- |
Price to Sales | 2.09x | 1.94x | 2.21x | 2.55x |
Price to Book | 2.15x | 2x | 2.19x | 1.95x |
EV/Revenue | 2.8x | 2.65x | 2.89x | 3.55x |
EV/EBITDA | 13.81x | 10.21x | 11.32x | 15.5x |
Price to FCF (P/FCF) | 75.77x | 32.15x | 13.35x | 18.09x |
EV/FCF | 101.57x | 43.9x | 17.47x | 25.25x |
FCF Yield | 1.32% | 3.11% | 7.49% | 5.53% |